任仕达（Randstad）：2025年全球生命科学与制药行业人才趋势报告（英文版）（20页）.pdf

《任仕达（Randstad）：2025年全球生命科学与制药行业人才趋势报告（英文版）（20页）.pdf》由会员分享，可在线阅读，更多相关《任仕达（Randstad）：2025年全球生命科学与制药行业人才趋势报告（英文版）（20页）.pdf（20页珍藏版）》请在三个皮匠报告上搜索。

1、2025 talent trends researchthemultiverse.talentlife sciences&pharma2AI reinvents the workplace but challenges persistThe life sciences and pharma sector stands at a critical crossroads.In our 2025 research,90%of global talent leaders across all sectors report that HRs influence continues to be eleva

2、ted a testament to the functions strategic importance;however,at just 85%,that number is lowest for the life sciences sector.At the same time,64%of life sciences leaders believe HR is still brought into business strategy discussions too late.To stay competitive in a complex landscape,leaders must re

3、think workforce strategies,increase AI adoption and prepare for continuous disruption all while keeping people at the center.As adoption expands,AI is driving rapid gains in especially in R&D and manufacturing.Companies are reporting two-year reductions in clinical trial timelines,400%faster drug de

4、sign,50%lower trial costs and more than 80%gains in manufacturing productivity.But workforce transformation remains complex,as,rising costs and shifting dynamics strain agility.According to Deloitte,83%of life sciences and pharma companies,and 75%expect shortages to worsen.Demand is especially high

5、for niche skills,such as bioinformatics,cell and gene therapy,and AI-driven diagnostics.As demand for specialized skills intensifies,companies that fail to adapt risk slowing innovation and losing ground.innovation talent shortages struggle to find skilled talentInnovation is soaring.Generative AI(G

6、AI)is unlocking a once-in-a-generation opportunity to reimagine the way we live and work.With the potential to deliver up to across the life sciences and pharmaceutical value chain,GAI is already accelerating how treatments are discovered and delivered.Its impact is growing more promising and more u